Moss WJ, Griffin DE. Global measles elimination. Nat Rev Microbiol. 2006;4(12):900–8.
CAS Article Google Scholar
WHO. Measles Fact Sheets. https://www.who.int/news-room/fact-sheets/detail/measles. Accessed 11 Nov 2021.
CDC. Measles Cases and Outbreaks. https://www.cdc.gov/measles/cases-outbreaks.html. Accessed 11 Nov 2021.
WHO. Measles in Europe: record number of both sick and immunized. https://www.euro.who.int/en/media-centre/sections/press-releases/2019/measles-in-europe-record-number-of-both-sick-and-immunized. Accessed 11 Nov 2021.
Kang JH. Review of Measles in Korea: quarantine and elimination. Infect Chemother. 2020;52(1):113–22.
Article Google Scholar
Four Western Pacific countries and areas are the first in their Region to be measles-free. 2014. https://www.who.int/westernpacific/news/item/20-03-2014-four-western-pacific-countries-and-areas-are-the-first-in-their-region-to-be-measles-free. Accessed.
Seok H, Park DW, Kim KN, Kim MJ, Kim SH, Kim JY, et al. Report of the Korean Society of Infectious Diseases Roundtable Discussion on Responses to the Measles Outbreaks in Korea in 2019. Infect Chemother. 2021;53(3):405–20.
Article Google Scholar
Choi SW, Cho EH, Shin NR. Analysis of the occurence of measles in Korea, 2019. In: The Korea Centers for Disease Control and Prevention; 2020. p.2445–58.
Park JW, Yu SN, Park E, Lee Y, Park SM, Jeon MH. Modified measles in an anti-measles immunoglobulin G-negative healthcare worker who had received two doses of measles-containing vaccine. Infect Chemother. 2019;51(3):305–9.
CAS Article Google Scholar
Chang HH, Kim SW, Kwon KT, Kim HI, Kim MJ, Ryu SY, et al. Preliminary report of seroprevalence of anti-measles immunoglobulin G among healthcare workers of 6 teaching hospitals of Daegu, Korea in 2019. Infect Chemother. 2019;51(1):54–7.
Article Google Scholar
Sundell N, Dotevall L, Sansone M, Andersson M, Lindh M, Wahlberg T, et al. Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections. Euro Surveill. 2019;24(17).
Cherry JD, Zahn M. Clinical characteristics of measles in previously vaccinated and unvaccinated patients in California. Clin Infect Dis. 2018;67(9):1315–9.
Article Google Scholar
Hahné SJ, Nic Lochlainn LM, van Burgel ND, Kerkhof J, Sane J, Yap KB, et al. Measles outbreak among previously immunized healthcare workers, the Netherlands, 2014. J Infect Dis. 2016;214(12):1980–6.
Article Google Scholar
Risco-Risco C, Masa-Calles J, López-Perea N, Echevarría JE, Rodríguez-Caravaca G. Epidemiology of measles in vaccinated people, Spain 2003–2014. Enferm Infecc Microbiol Clin. 2017;35(9):569–73.
Article Google Scholar
Minetti A, Bopp C, Fermon F, François G, Grais RF, Grout L, et al. Measles outbreak response immunization is context-specific: insight from the recent experience of Médecins Sans Frontières. PLoS Med. 2013;10(11):e1001544.
Article Google Scholar
Minetti A, Hurtado N, Grais RF, Ferrari M. Reaching hard-to-reach individuals: nonselective versus targeted outbreak response vaccination for measles. Am J Epidemiol. 2014;179(2):245–51.
Article Google Scholar
Gastañaduy PA, Banerjee E, DeBolt C, Bravo-Alcántara P, Samad SA, Pastor D, et al. Public health responses during measles outbreaks in elimination settings: strategies and challenges. Hum Vaccin Immunother. 2018;14(9):2222–38.
Article Google Scholar
Albrecht P, Herrmann K, Burns GR. Role of virus strain in conventional and enhanced measles plaque neutralization test. J Virol Methods. 1981;3(5):251–60.
CAS Article Google Scholar
Griffin DE. Measles virus in fields virology. Philadelphia: Lippincott, Williams & Wilkins; 2020.
Google Scholar
Cohen BJ, Audet S, Andrews N, Beeler J. Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine. 2007;26(1):59–66.
CAS Article Google Scholar
Mercader S, Garcia P, Bellini WJ. Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings. Clin Vaccine Immunol. 2012;19(11):1810–7.
CAS Article Google Scholar
Sowers SB, Rota JS, Hickman CJ, Mercader S, Redd S, McNall RJ, et al. High concentrations of measles neutralizing antibodies and high-avidity measles IgG accurately identify measles reinfection cases. Clin Vaccine Immunol. 2016;23(8):707–16.
CAS Article Google Scholar
Iwamoto M, Hickman CJ, Colley H, Arciuolo RJ, Mahle CE, Deocharan B, et al. Measles infection in persons with secondary vaccine failure, New York City, 2018–19. Vaccine. 2021;39(38):5346–50.
Article Google Scholar
Kurata T, Kanbayashi D, Egawa K, Kinoshita M, Yoshida H, Miyazono M, et al. A measles outbreak from an index case with immunologically confirmed secondary vaccine failure. Vaccine. 2020;38(6):1467–75.
CAS Article Google Scholar
Zhang Z, Chen M, Ma R, Pan J, Suo L, Lu L. Outbreak of measles among persons with secondary vaccine failure, China, 2018. Hum Vaccin Immunother. 2020;16(2):358–62.
CAS Article Google Scholar
Cheng VCC, Wong SC, Wong SCY, Sridhar S, Chen JHK, Yip CCY, et al. Measles outbreak from Hong Kong International Airport to the hospital due to secondary vaccine failure in healthcare workers. Infect Control Hosp Epidemiol. 2019;40(12):1407–15.
Article Google Scholar
Kang HJ, Han YW, Kim SJ, Kim YJ, Kim AR, Kim JA, et al. An increasing, potentially measles-susceptible population over time after vaccination in Korea. Vaccine. 2017;35(33):4126–32.
Article Google Scholar
Jung J, Kim SK, Kwak SH, Hong MJ, Kim SH. Seroprevalence of measles in healthcare workers in South Korea. Infect Chemother. 2019;51(1):58–61.
Article Google Scholar
Anichini G, Gandolfo C, Fabrizi S, Miceli GB, Terrosi C, Gori Savellini G, et al. Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy. Vaccines (Basel). 2020;8(1).
Christenson B, Böttiger M. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine. 1994;12(2):129–33.
CAS Article Google Scholar
Fiebelkorn AP, Coleman LA, Belongia EA, Freeman SK, York D, Bi D, et al. Measles virus neutralizing antibody response, cell-mediated immunity, and immunoglobulin G antibody avidity before and after receipt of a third dose of measles, mumps, and rubella vaccine in young adults. J Infect Dis. 2016;213(7):1115–23.
CAS Article Google Scholar
Lin WH, Vilalta A, Adams RJ, Rolland A, Sullivan SM, Griffin DE. Vaxfectin adjuvant improves antibody responses of juvenile rhesus macaques to a DNA vaccine encoding the measles virus hemagglutinin and fusion proteins. J Virol. 2013;87(12):6560–8.
CAS Article Google Scholar
Kaaijk P, Wijmenga-Monsuur AJ, van Houten MA, Veldhuijzen IK, Ten Hulscher HI, Kerkhof J, et al. A third dose of measles-mumps-rubella vaccine to improve immunity against mumps in young adults. J Infect Dis. 2020;221(6):902–9.
CAS PubMed Google Scholar
Marlow MA, Marin M, Moore K, Patel M. CDC guidance for use of a third dose of MMR vaccine during mumps outbreaks. J Public Health Manag Pract. 2020;26(2):109–15.
Article Google Scholar
Nair N, Moss WJ, Scott S, Mugala N, Ndhlovu ZM, Lilo K, et al. HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection. J Infect Dis. 2009;200(7):1031–8.
CAS Article Google Scholar
Kontio M, Jokinen S, Paunio M, Peltola H, Davidkin I. Waning antibody levels and avidity: implications for MMR vaccine-induced protection. J Infect Dis. 2012;206(10):1542–8.
CAS Article Google Scholar
Iankov ID, Penheiter AR, Griesmann GE, Carlson SK, Federspiel MJ, Galanis E. Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cells. Virus Res. 2013;172(1–2):15–23.
CAS Article Google Scholar
Isa MB, Martínez L, Giordano M, Passeggi C, de Wolff MC, Nates S. Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals. Clin Diagn Lab Immunol. 2002;9(3):693–7.
CAS PubMed PubMed Central Google Scholar
Toptygina AP, Pukhalsky AL, Alioshkin VA. Immunoglobulin G subclass profile of antimeasles response in vaccinated children and in adults with measles history. Clin Diagn Lab Immunol. 2005;12(7):845–7.
CAS PubMed PubMed Central Google Scholar
Correa VA, Rodrigues TS, Portilho AI, Trzewikoswki de Lima G, De Gaspari E. Modified ELISA for antibody avidity evaluation: the need for standardization. Biomed J. 2021;44(4):433–8.
Article Google Scholar
Comments
Post a Comment